Author: admin

  • ‘Bring the House Down’ review: Charlotte Runcie lampoons Fringe critic

    ‘Bring the House Down’ review: Charlotte Runcie lampoons Fringe critic

    Book Review

    Bring the House Down

    By Charlotte Runcie
    Doubleday: 304 pages, $28
    If you buy books linked on our site, The Times may earn a commission from Bookshop.org, whose fees support independent bookstores

    Any profession can corrupt its practitioners — and arts critics are no exception. Are they enlightened standard-setters dragging us back from a cultural abyss — or deformed exiles from the arts who, with sharpened pens and bent backs, are ready to pounce on plot-holes and devour careers at a moment’s notice?

    If Charlotte Runcie’s debut novel, “Bring the House Down,” is anything to go by, it’s a bit of both. The book centers around four heady weeks at the Edinburgh Fringe Festival, which begins the unraveling of two newspaper critics who have traveled up from London to cover the sprawling performance art event. Runcie, a former arts columnist for the Daily Telegraph, has created something so delightfully snackable that you may, as I did, gulp it down in two or three sittings.

    Runcie’s anti-hero is theater critic Alex Lyons. Alex gives everything he reviews either one star or five, and the latter are vanishingly rare. He bemoans a world of “online shopping reviews,” where “five stars has come to mean the baseline, rather than outstanding,” and so insists on panning almost everything he sees. What’s bad for artists is good for him: His reviews become desperately sought-after career makers or breakers. “The paper didn’t allow Alex to award zero stars. Otherwise, he’d do it all the time.”

    “Bring the House Down”

    (Doubleday)

    We learn about Alex’s story through our narrator Sophie Ridgen, his colleague who, despite being in her mid-30s like Alex, is on a very different track. Alex rose quickly through the newspaper’s ranks, and his reviews are featured on the front page almost daily. Sophie continues to toil as a junior culture writer, picking up whatever scraps nobody else wants. Sophie is also a new mom, overworking to compensate for time lost to maternity leave. She feels uncomfortable in her post-pregnancy body, exhausted and frustrated with her husband. Alex, on the other hand, finds it “embarrassingly easy” to get laid.

    But Alex’s glory days are numbered. Early on at the Fringe, he sees a one-woman show that, unsurprisingly, he hates. He writes a review as devastating as it is personal (calling the star a “dull, hectoring frump,” her voice a “high-pitched whine”). All of this would be business as usual for Alex except for one problem: After quickly filing his review of the show, he bumps into Hayley Sinclair, its creator and star, in a bar. He takes her home and sleeps with her. He knew the one star was waiting for her; she did not.

    When she finds out, there is hell to pay. Hayley transforms her nightly show into the “Alex Lyons Experience,” collecting testimony from his ex-girlfriends and lovers, or even those who have simply received bad reviews from him. Over the following weeks her show swells into a Greek chorus of one man’s wrongs. The whole nation, including members of Parliament, have hot takes (the performance is livestreamed). It doesn’t help his case that Alex is a bit of a nepo baby, as his mother Judith is an actor whose name would be recognized in most British households.

    Sophie, living with Alex in the company-rented flat, has a front row seat to his public unraveling. She watches the livestreams with guilty awe, stalks Alex and Hayley compulsively online, and feverishly scans social media for the latest gossip (Runcie is great at writing a fake mean Tweet/X dispatch). She starts missing calls with her husband and their toddler son, as she becomes fully obsessed with the drama unfolding in Edinburgh.

    As she continues to inhabit the same flat as her colleague, Sophie is increasingly questioned by others as to whose side she’s on, Alex or Hayley’s. For much of the book, she seems unable to make up her mind. She refuses to give up on Alex, and increasingly becomes his only source of companionship, which she can’t help but find flattering. But she also finds herself sympathetic to and magnetized by Hayley, whose popularity is blossoming on the Fringe circuit and beyond.

    While Alex and Hayley both appear to possess other-worldly levels of charisma, one flaw with Runcie’s novel is that this is something we are repeatedly told, rather than shown. Alex spends most of the book being condescending to Sophie, and yet she is transfixed by him. “He had the strange ability to make you feel as if you were the only person who was in on a joke, the only person who understood some fundamental truth about the world that escaped other people.” This feels unsatisfyingly generic, like something you might find in an online wedding vows template.

    We are at least given more backstory and a more plausible explanation for Sophie’s fascination with Alex: the ego trip. Having been dragged down by motherhood, a rocky marriage, and grief over the death of her own mother, Sophie enjoys Alex’s increasing dependence on her, a lone rock of support amid an ocean of alienation. There is something undeniably delicious in watching someone you revere fall to their knees, and Sophie begins to see in Alex “a tiny flickering of fear, at first only visible as a barely perceptible interruption to his arrogance, like a power cut that dims the lights for just a hundredth of a second.”

    Hayley, unfortunately, never quite comes to life in the same way. And it remains unclear why her show, which is essentially a litany of (legitimate) complaints about a real-life terrible man with some added pyrotechnics, takes Edinburgh and the entire country by such storm. “I find I can’t explain why it had the effect that it did,” Sophie tells us. “This wasn’t theater, not really; it was a happening. The audience weren’t spectators anymore, but a silent, connected web of righteous energy.” Without more to go on, we have no choice but to take her word for it.

    The result feels like a missed opportunity to interrogate some important questions. How much does the identity (gender, race, or class) of the critic matter when it comes to their ability to judge art? What about the identity of the artist themselves? In other words, who shall criticize the critics? Readers may leave Runcie’s novel feeling that some of these questions go unanswered, but this deeply entertaining novel is nonetheless well worth the price of admission.

    Mills is a writer and human rights researcher who has worked for Amnesty International, Human Rights Watch, the Wall Street Journal and Associated Press. She lives in New York.

    Continue Reading

  • Dow will shut down three upstream European assets in response to structural challenges in the region

    Dow will shut down three upstream European assets in response to structural challenges in the region

    • Right-sizing upstream regional capacity, reducing merchant sale exposure, and removing higher-cost, energy-intensive assets
    • Building on April 2025 announcement through actions across the Company’s three operating segments to support European profitability
    • Asset shutdowns will result in Op. EBITDA uplift beginning in 2026, ramping to 50% of the ~$200 million target by end-2027 and full delivery by 2029

    MIDLAND, Mich., July 7, 2025 /PRNewswire/ — Dow (NYSE: DOW) announced today that, as a follow-up to the European asset actions first announced in April 2025, its Board of Directors has approved the shutdown of three upstream assets in Europe, in addition to certain corporate and other assets across the Company’s global asset footprint:

    • Packaging & Specialty Plastics: Ethylene cracker in Böhlen, Germany; shutdown expected in 4Q27
    • Industrial Intermediates & Infrastructure: Chlor-alkali & vinyl (CAV) assets in Schkopau, Germany; shutdown expected in 4Q27
    • Performance Materials & Coatings: Basics siloxanes plant in Barry, U.K.; shutdown expected mid-year 2026

    The shutdown of upstream assets in Europe will right-size regional capacity, reduce merchant sale exposure, and remove higher-cost, energy-intensive portions of Dow’s portfolio in the region. This will improve our ability to supply profitable derivative demand and optimize margins.

    “Our industry in Europe continues to face difficult market dynamics, as well as an ongoing challenging cost and demand landscape,” said Jim Fitterling, Dow chair and CEO. “Over the past decade, we have demonstrated Dow’s commitment to operating with a best-owner mindset by taking proactive actions across higher-cost or non-strategic assets. Looking ahead, we remain committed to realizing the value of our incremental growth investments and enhancing profitability and cash flow through more than $6 billion in near-term cash support.”

    In April 2025, the Company announced it had identified three assets in Europe for action across all of its operating segments. On June 30, 2025, Dow’s Board of Directors approved restructuring actions to rationalize the Company’s global asset footprint, including these three assets as part of its European review, and certain corporate and other assets.

    Dow’s actions to shut down these assets will result in an Operating EBITDA uplift beginning in 2026, ramping to 50% of the approximate $200 million target by year-end 2027 with full delivery by 2029, with a cash outlay of approximately $500 million over four years.

    As a result of these actions, the Company will record charges ranging from $630 million to $790 million, for both non-cash items—such as asset write-downs and write-offs—and cash items, such as exit and disposal of assets, as well as severance and related benefit costs.

    The shutdown of the assets is expected to begin in mid-2026 and is estimated to be complete by the end of 2027, with potential decommissioning and demolition to continue into 2029 as needed.

    Approximately 800 Dow roles will be impacted as a result of these actions. These roles are in addition to the $1 billion cost savings actions announced in January that included a workforce reduction of approximately 1,500 Dow roles globally.

    Dow will involve local stakeholders as defined in each country and in compliance with relevant information and consultation processes.

    Asset

    Estimated

    Shutdown
    Timing

    Implementation
    Timing

    Cash Outlay
    ($MM)

    Op. EBITDA
    Uplift at Full
    Run Rate
    ($MM)

    Average Capex
    Avoidance

    ($MM/year)

    P&SP: Böhlen Cracker

    4Q27

    2027 – 2029

    $130

    $60

    $20

    II&I: Schkopau CAV

    4Q27

    2026 – 2029

    $80

    $10

    $15

    PM&C: Barry Siloxane

    Mid-2026

    2026 – 2029

    $180

    $90

    $20

    Corporate and Other Actions

    2026 – 2028

    2026 – 2028

    $120

    $40

    $5

    Total



    ~$500

    ~$200

    ~$60

    About Dow
    Dow (NYSE: DOW) is one of the world’s leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, focused innovation, leading business positions and commitment to sustainability enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 30 countries and employ approximately 36,000 people. Dow delivered sales of approximately $43 billion in 2024. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us and our ambition to be the most innovative, customer-centric, inclusive and sustainable materials science company in the world by visiting www.dow.com.

    For further information, please contact:


    Investors:                                                                   

    Media:

    Andrew Riker                                                             

    Rachelle Schikorra

    [email protected] 

    [email protected]

    X: https://twitter.com/DowNewsroom 
    Facebook: https://www.facebook.com/dow/ 
    LinkedIn: http://www.linkedin.com/company/dow-chemical 
    Instagram: http://instagram.com/dow_official 

    Cautionary Statement about Forward-Looking Statements

    Certain statements in this press release are “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases.

    Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow’s control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow’s products; Dow’s expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow’s contemplated capital and operating projects; Dow’s ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow’s products and services and ability to compete in such markets; Dow’s ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow’s products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow’s intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow’s significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow’s information technology networks and systems, including the impact of cyberattacks; risks related to Dow’s separation from DowDuPont Inc. such as Dow’s obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow’s business.

    Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and the Company’s subsequent Quarterly Reports on Form 10-Q. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow’s business. Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

    ®TM Trademark of The Dow Chemical Company or an affiliated company of Dow       

    SOURCE The Dow Chemical Company


    Continue Reading

  • EHGO and Photonetco Form Exclusive National Partnership to Expand in China’s Office Equipment Market

    SHANGHAI, July 7, 2025 /PRNewswire/ — Eshallgo Inc. (Nasdaq: EHGO), a leading provider of integrated office solutions in China, today announced that its wholly owned subsidiary, Shanghai ESHALLGO Enterprise Development (Group) Co., Ltd. (“ESHALLGO Group”), has entered into a nationwide strategic partnership agreement (the “Agreement”) with Tianjin Photonetco Electronic Technology Co., Ltd. (“Photonetco”), one of China’s top three office equipment manufacturers.

    The Agreement appoints EHGO as Photonetco’s exclusive national strategic partner, underscoring a critical advancement in EHGO’s efforts to expand within China’s growing office equipment market.

    According to Cognitive Market Research, China’s office printer market alone is valued at over USD 5 billion as of 2024, and is expected to grow at a compound annual growth rate (CAGR) of 6% through 2031. When including office consumables, services, and broader enterprise integration, the total addressable market exceeds USD 10 billion, driven by national policies promoting domestic technology adoption, data security, and procurement independence among Chinese enterprises.

    Under the agreement, Photonetco will provide EHGO with more than 10 custom-developed printer models, ranging from entry-level to enterprise-grade categories, and grant EHGO nationwide distribution rights for both hardware and consumables. EHGO will also gain access to Photonetco’s comprehensive national after-sales service and maintenance network. In addition, Photonetco will support EHGO through professional technical training, authorized service station support, formal authorization documentation for EHGO and its affiliates, and the provision of promotional and marketing materials as needed to strengthen market development and brand promotion efforts.

    In return, EHGO will be committed to meeting minimum purchase targets and maintaining sufficient inventory to ensure uninterrupted nationwide supply. EHGO will strictly adhere to Photonetco’s rigorous channel management and compliance requirements, including regular sales reporting, transparent project registration, and strict protection of brand reputation and market integrity. This strong framework underscores both parties’ dedication to long-term collaboration and the high standards required to serve China’s growing enterprise market.

    The two companies have a longstanding commercial relationship through Junzhang Digital Technology (Shanghai) Co., Ltd., an EHGO subsidiary that has been a licensed distributor of Photonetco products. This new agreement formalizes and significantly expands the scope of that relationship.

    “Localization is reshaping China’s enterprise procurement landscape. Our partnership with Photonetco enables EHGO to accelerate its strategic presence during this transition by delivering secure, high-performance, and cost-effective solutions tailored for domestic demand,” said the EHGO management team.

    Founded over 70 years ago, Photonetco introduced China’s first fully self-developed black-and-white laser printer in 2010 and has remained at the forefront of secure printing solutions through continuous investment in independent R&D and intelligent manufacturing. This collaboration strengthens EHGO’s ability to offer a differentiated and competitive office equipment portfolio to Chinese enterprises and government entities alike.

    The partnership reinforces EHGO’s mission to support national industrial upgrading, broaden its proprietary offerings, and drive long-term shareholder value through participation in one of the most promising segments of China’s technology-enabled enterprise market.

    Sources: Cognitive Market Research, Office Printer Market Report – China, 2024–2031
    https://www.cognitivemarketresearch.com/office-printer-market-report

    About Eshallgo Inc

    Eshallgo, Inc is one of China’s leading office solution providers with a global perspective. The company focuses on two market segments: the sales and leasing of office supplies, as well as after-sales maintenance and repair services. With a wide-ranging presence across 20 provinces in China, its mission is to become an all-in-one office integrator and service provider, offering competitive comprehensive office solutions and services, expanding into service markets beyond office equipment, and continuously creating maximum value for customers. For more information, please visit the company’s official website at www.eshallgo.com and ir.eshallgo.com

    Forward-Looking Statements

    All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.

    For more information, please contact:
    Tony Sklar
    SW Investor Relation
    [email protected]

    SOURCE Eshallgo Inc

    Continue Reading

  • ECT Proponents Deny Harms as the Tide Begins to Shift

    ECT Proponents Deny Harms as the Tide Begins to Shift

    Recent guidance from the World Health Organization (WHO) and American Psychiatric Association (APA) has finally acknowledged the risks of electroconvulsive therapy (ECT). These organizations focus on ensuring that patients receive informed consent, acknowledging the risks of long-term memory loss and other health concerns due to the procedure, and recommend against the use of ECT in children.

    But this has stirred up ECT promoters like Joseph Cooper and colleagues, who published a recent opinion piece in The Lancet Psychiatry defending ECT. Yet according to other researchers (published the same day, also in The Lancet Psychiatry), Cooper et al. cherry-pick data and ignore the large body of research on ECT’s harms. Worse, Cooper et al. “directly oppose” the principle of informed consent, according to their critics.

    The critics were led by Michelle Funk, a key figure in WHO’s mental health policy, and also included ECT survivors like Sarah Price Hancock, and researchers like John Read.

    “Denying people full information and the right to make autonomous decisions not only violates their rights but also reinforces stigma and disempowerment. We stand by the guidance developed with the input of leading experts and its call for legislation grounded in human rights,” write Funk et al.

    You’ve landed on a MIA journalism article that is funded by MIA supporters. To read the full article, sign up as a MIA Supporter. All active donors get full access to all MIA content, and free passes to all Mad in America events.

    Current MIA supporters can log in below.(If you can’t afford to support MIA in this way, email us at [email protected] and we will provide you with access to all donor-supported content.)

    Donate

    ECT, or “electroshock,” is a controversial procedure that involves electrocuting the brain to deliberately induce seizures. There is no consensus on how this might reduce mental health problems. The procedure results in adverse cognitive effects that can last for years, including persistent memory loss in over a third of patients. Life-threatening cardiac problems are also common, even in those with no history of heart problems.

    Although opinion pieces claim that ECT is a life-saving procedure, the data to support its effectiveness simply isn’t there. Instead, studies show that after receiving treatment, people who receive ECT are 45 times more likely to die by suicide than the general population. When compared to those with the same severity of mental health problems, a study of over 70,000 veterans found no difference between those who received ECT and those who did not.

    Researchers have noted that only 11 placebo-controlled studies of ECT’s effectiveness for depression have ever been conducted, and all took place prior to 1985. None were double-blind. Fewer than half (4 out of 11) of these small, old, biased studies found ECT to beat placebo.

    In a 2020 study, researchers including Read as well as renowned Harvard researcher Irving Kirsch concluded that “there is no evidence that ECT is effective for its target demographic—older women, or its target diagnostic group—severely depressed people, or for suicidal people, people who have unsuccessfully tried other treatments first, involuntary patients, or adolescents.”

    Funk et al.’s Response to Cooper et al.

    According to Funk and colleagues, Cooper et al. cite a misleading 1994 paper to suggest that ECT does not cause brain damage. Yet, Funk et al. write, “the study provides no direct support for this claim, shows no improvement in brain function, and in fact reports structural brain changes that might be maladaptive, contradicting the authors’ interpretation of these changes as inherently beneficial.”

    Cooper et al. also cite a single study with no control group to suggest that people are overwhelmingly happy with receiving ECT, even when forced to receive it without informed consent. However, Funk et al. note that the majority of research debunks this claim—for instance, a systematic literature review combining various studies that found long-lasting dissatisfaction, side effects, and trauma as a result of ECT.

    Beyond cherry-picking single studies to make their case, while ignoring the majority of ECT research, Cooper et al. also rail against WHO’s ethical complaints. Funk et al. note that the APA and the UK’s NICE are particularly concerned about the effects of electrocuting and causing seizures in the developing brains of children; evidence suggests this can be even more detrimental than it is for adults. Cooper et al. disagree, trotting out the old unsupported notion that ECT saves children from suicide.

    Another moral issue: WHO guidance has compared forced treatment to torture and suggested that individuals have the right to a say in their own medical care and should be told of potential risks and benefits. Again, Cooper et al. disagree, taking the paternalistic attitude that doctors should not provide informed consent and should not give patients a say in what they do to their bodies. Instead, ECT should be forced and patients should not be warned of potential risks, lest they try to avoid the procedure.

    Funk et al. write, “The safety, ethics, and effectiveness of ECT remain contested around the world and among top authorities in the field. We call on Cooper and colleagues to align their position with the scientific evidence and human rights standards. Informed consent, safeguards, and respect for autonomy are not barriers, they are the foundation of ethical care.”

     

    ****

    Funk, M., Drew, N., Pathare, S., Encalada, A. V., McGovern, P., Hancock, S. P., & Read, J. (2025). Electroconvulsive therapy: reaffirming the case for caution, consent, and rights. The Lancet Psychiatry. Published on June 23, 2025. DOI: 10.1016/S2215-0366(25)00192-0 (Link)

    Continue Reading

  • Ricky Hatton comeback – The best night of Hatton's career against pound-for-pound legend – dazn.com

    1. Ricky Hatton comeback – The best night of Hatton’s career against pound-for-pound legend  dazn.com
    2. Ricky Hatton: Former world champion announces comeback against Eisa Al Dah in December  BBC
    3. Ricky Hatton returns – Hatton made to suffer against the legendary Manny Pacquiao  dazn.com
    4. Ricky Hatton, 46, confirms boxing comeback against Eisa Al Dah  The Express Tribune
    5. Coronation Street’s Claire Sweeney’s three word message to ex Ricky Hatton after major announcement  Liverpool Echo

    Continue Reading

  • Amazon Fire HD 10 tablet is 48% off in early Prime Day deal

    Amazon Fire HD 10 tablet is 48% off in early Prime Day deal

    Amazon Prime Day may not officially start until 8 July, but the retailer already has some brilliant early deals online.

    Amazon has slashed the price of its HD 10 tablet by a huge 48%. Originally retailing at £197.98, the device is now available for £102.98 as part of the retailer’s early Prime Day deals.

    While it’s not the lowest price the HD 10 tablet has been discounted to in the past – the device was reduced further in the Amazon Spring Deals Day event in March this year – it’s still a substantial saving.

    It’s worth noting that this particular deal is a bundle, as the device comes with two anti-glare screen protectors designed to protect against scratches and smudges. The protectors also come with a cleaning cloth and applicator card for a smooth application process.

    It’s important to remember that in order to take advantage of this discount (and any Prime Day deals occurring this week), customers must have an Amazon Prime membership.

    Prime Members’ Exclusive Deal

    Amazon Amazon Fire HD 10 tablet (64GB, ad-supported), plus 2x anti-glare screen protectors

    Amazon Fire HD 10 tablet (64GB, ad-supported), plus 2x anti-glare screen protectors

    Now 48% Off

    Credit: Amazon

    Amazon Prime membership costs £8.99 per month or £95 per year, and as well as access to Prime Day deals, members can enjoy One-Day delivery on orders (where available) and access to the Prime Video streaming service.

    The Amazon Fire HD 10 tablet is part of a new wave of Fire HD 10 launches that went on sale at the end of 2023, and is the newest model of this product.

    Amazon says that the tablet has 25% faster performance than the 11th generation Fire HD 10, and is also 30g lighter.

    The front-facing camera is also upgraded from 2 MP to 5 MP for better-quality pictures and video calling capabilities.

    While the Fire HD 10 tablet is available in a choice of 32 or 64 GB, in a choice of three shades – black, lilac and ocean blue – the device on offer has 64 GB storage and comes in the black colourway.

    It also features ads, which means that it “displays sponsored screensavers on your device’s lock screen and in sleep mode”.

    The Fire HD 10 tablet also has up to 13 hours of battery life (perfect for binge watching your Prime Video favourites on the go), and comes with up to 1 TB expandable storage (sold separately).

    You can expect more discounts from Amazon in its Prime Day event over the coming days, so watch out for more offers landing imminently.

    Shop Sky TV, broadband and mobile deals
    Shop Sky TV, broadband and mobile deals
    Stranger Things Hellfire Club Dice Dangle Charm
    Stranger Things Hellfire Club Dice Dangle Charm
    Credit: Pandora
    Shop Claudia Winkleman's Traitors looks
    Shop Claudia Winkleman’s Traitors looks
    Credit: BBC / Studio Lambert
    On Sale

    Richard Osman: We Solve Murders

    Richard Osman: We Solve Murders
    Credit: Viking
    Shop PS5 consoles
    Shop PS5 consoles
    Credit: PlayStation
    Shop Alison Hammond's outfits
    Shop Alison Hammond’s outfits
    Credit: Mark Bourdillon
    Apple TV+ 7-day free trial
    Apple TV+ 7-day free trial
    Credit: Apple TV+
    Sign up for Disney+
    Sign up for Disney+
    Credit: Chuck Zlotnick
    The Street of Lies: An Official Coronation Street Interactive Novel
    The Street of Lies: An Official Coronation Street Interactive Novel
    Credit: Octopus Books
    Death in Paradise: The Puzzle Book
    Death in Paradise: The Puzzle Book
    Credit: BBC Books

    Continue Reading

  • Geo Films’ horror thriller Deemak wins big at SCO film festival

    Geo Films’ horror thriller Deemak wins big at SCO film festival

    Deemak director Rafay Rashdi and lead actor Sonya Hussyn receive the award at Shanghai Cooperation Organisation (SCO) Film Festival 2025. — Screengrab via Instagram@rafayrashdi

    Pakistani horror hit Deemak has gained international recognition, winning the Best Editing award at the Shanghai Cooperation Organisation (SCO) Film Festival 2025 held in Chongqing, China.

    The horror thriller was among two Pakistani films honoured at the event, alongside Nayab, showcasing the growing global impact of Pakistani cinema.

    Directed by Rafay Rashdi and starring Sonya Hussyn, Samina Peerzada, and Faysal Quraishi, Deemak has stood out for its gripping narrative and technical finesse. 

    Following the award announcement, Rashdi expressed his gratitude on Instagram, calling it a “historic win for Pakistani cinema on an international stage.” 

    He thanked the SCO, the Ministry of Information, and those who supported the film’s vision. “Pakistan Zindabad,” he added, sharing a photo with the award and lead actor Sonya Hussyn.

    Hussyn, who attended the festival, also celebrated the honour on social media, writing, “Our film Deemak bring home an award at the prestigious film festival,” and calling it a proud moment for Pakistan.

    Produced and presented by Geo Films, Deemak was released nationwide on Eidul Adha and quickly became a box office phenomenon.

    It set a new record for the horror genre in the country, collecting Rs70 million in just its first two days. Viewers praised the film for delivering a chilling yet emotionally resonant experience, with many crediting Geo Films for backing such a bold and innovative project.

    The film explores themes of horror, folklore, and complex family dynamics.

    Written by Syed Murad Ali, Rashdi, and Ayesha Muzaffar, Deemak features a stellar cast including Javed Sheikh and Bushra Ansari alongside the leads. Its combination of fear, drama, and social commentary has resonated deeply with audiences.

    Geo Films, known for producing acclaimed titles such as Khuda Ke Liye, Bol, Teefa in Trouble, The Legend of Maula Jatt, and Donkey King, continues its legacy of supporting groundbreaking Pakistani cinema. 

    With Deemak now earning accolades on the international stage, the film marks yet another milestone for the studio and for the country’s evolving film industry.


    Continue Reading

  • Israel, Hamas set for Gaza ceasefire talks as Netanyahu due to meet Trump – Reuters

    1. Israel, Hamas set for Gaza ceasefire talks as Netanyahu due to meet Trump  Reuters
    2. Cautious optimism for Gaza ceasefire breakthrough as Netanyahu visits US  BBC
    3. Trump to host Netanyahu, hopes for Israel-Hamas deal ‘this week’  Dawn
    4. What’s in Trump’s ceasefire proposal and can it end Israel’s war on Gaza?  Al Jazeera
    5. Israel, Hamas said to resume indirect Doha talks as Netanyahu set to meet Trump at White House  The Times of Israel

    Continue Reading

  • MembersCap launches tokenised institutional-grade reinsurance fund

    MembersCap launches tokenised institutional-grade reinsurance fund

    Bermuda-regulated investment manager, Members Capital Management (MembersCap), has completed an investment in its initial portfolio through the fund, MCM Fund I, the first tokenised institutional-grade reinsurance fund designed for sophisticated digital asset investors and traditional allocators.

    Positioned as an alternative to private equity, venture capital, and fixed income strategies, MCM Fund I provides investors with regulated and collateralised access to reinsurance through direct exposure to natural catastrophe and cyber reinsurance contracts sourced through blue-chip global partners.

    All portfolio trades were executed with global reinsurers and top-tier Lloyd’s of London syndicates, and are sourced through the top three global reinsurance brokers.

    The fund aims to provide access to reinsurance income for a rapidly expanding capital base of new investors seeking diversified and uncorrelated investment alternatives with attractive yield and structured liquidity.

    The launch represents the growing importance of funds structuring their offerings to capitalise on the ongoing convergence between traditional finance and digital assets.

    Register for the Artemis London 2025 cat bond and ILS market conference

    Additionally, MembersCap was selected as the first fund in the real-world assets category on the Archax platform, alongside tokenised offerings from other institutions like BlackRock, State Street, and Aberdeen.

    Backed by Solana, Aptos, and Cardano and supported by Coinbase, Archax, Apex Group, and Envelop Risk, MembersCap has selected the Solana, Aptos, Cardano, and Base protocols to provide access to investors aiming to invest in eligible cryptocurrencies.

    Despite being highly yield-generative, the reinsurance sector has historically been reserved for pension plans, sovereign wealth funds, and other institutional giants. Increasingly, both crypto-native investors and smaller traditional allocators are “seeking refuge from market volatility” by accessing reinsurance as a stable, diversified income stream for a balanced portfolio and to enhance returns.

    For Web3 treasuries, foundations, and institutions, the fund aims to deliver high-yield opportunities and structured liquidity, derived from high-quality, real-world reinsurance returns, without exposure to DeFi volatility and over-concentration in altcoins.

    Lloyd Wahed, Co-Founder and Chief Executive Officer, MembersCap, commented, “Every generation is presented with new technologies that unlock economic opportunity. To us, tokenisation and the blockchain represent access to better asset management for a different class of investor. We’re excited to be one of the first institutional funds to emerge from this space.”

    Patrick Barrett, Co-Founder and Chief Operating Officer, MembersCap, added, “Our investors– digital asset institutions, family offices, HNWIs —want to meet their goals of resiliency and long-term sustainable growth through new and more efficient means. With this novel approach, we’re seeing these investors view reinsurance as a core part of their portfolio for the first time.”

    Dr. Benjamin Fox, Co-Founder and Chief Investment Officer, MembersCap, said, “This launch proves that tokenisation can bring new capital to help address the growing insurance protection gap by lowering barriers and providing access to the private reinsurance market. Our tokenised model enables a new cohort of investors to participate pari passu alongside large institutions in an uncorrelated asset class with a track record of reliable, attractive returns.”

    Print Friendly, PDF & Email

    Continue Reading

  • Wimbledon 2025: De Minaur v Djokovic, Cilic v Cobolli, Alexandrova v Bencic and more – live | Wimbledon 2025

    Wimbledon 2025: De Minaur v Djokovic, Cilic v Cobolli, Alexandrova v Bencic and more – live | Wimbledon 2025

    Today’s order of play

    Here’s a look at today’s men’s and women’s singles matches in the round of 16:

    Centre Court (1.30pm BST/8.30am ET)

    Alex de Minaur (11) v Novak Djokovic (6)
    Mirra Andreeva (7) v Emma Navarro (10)
    Jannik Sinner (1) v Grigor Dimitrov (19)

    No 1 Court (1pm BST/8am ET)

    Ekaterina Alexandrova (18) v Belinda Bencic
    Ben Shelton (10) v Lorenzo Sonego
    Iga Świątek (8) v Clara Tauson (23)

    No 2 Court (11am BST/6am ET)

    Marin Čilić v Flavio Cobolli (22)
    Liudmila Samsonova (19) v Jessica Bouzas Maneiro

    Share

    Updated at 

    Key events

    Thanks Bryan and greetings everyone. Djokovic has played beautifully until this point, and I must say I didn’t expect him to struggle today – pretty much everything De Minaur does well, he does better. And yet here we are, the Demon up 4-1 and, as I type, he holds for 5-1. Real talk, he’s not actually playing that well, Djokovic is just enduring a shocker.

    Share

    Continue Reading